BOSTON, March 2, 2020 /PRNewswire/ -- Seniorlink, Inc., a leading tech-enabled health services company, today announced the implementation of a new regional corporate structure as well as the promotion of two tenured executives both to the position of Regional Director, Community Partnerships.

Company Enters Mature Colorado Cannabis Market with High Quality, Award-Winning Product Line WAKEFIELD, Mass., March 2, 2020 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading vertically integrated cannabis operator in the United States, will acquire BlueKudu, a

Paul Lévesque will be appointed as President and CEO, replacing Luc Tanguay, who is retiring MONTREAL, March 2, 2020 /PRNewswire/ - The board of directors of Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) is pleased to announce the appointment of Paul Lévesque as the company's President and

SAN DIEGO, March 2, 2020 /PRNewswire/ -- IQ4I Research & Consultancy published a new report on "Proteomics Global Market – Forecast To 2026".

YOKNEAM, Israel, March 2, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy, Chairman and Chief Executive Officer, will present at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Mi

DALLAS, March 2, 2020 /PRNewswire/ -- FX received 510k clearances for their Glenoid Baseplate with a Central Screw and 32mm Glenosphere and Humeral Cups for reverse shoulder arthroplasty.

SAN DIEGO, March 2, 2020 /PRNewswire/ -- Primmune Therapeutics today announced that it has raised $7 million in seed financing to support the developmen

BOTHELL, Wash., March 2, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of best-in-class bioproduction tools for

SAN DIEGO, March 2, 2020 /PRNewswire/ -- Agragene, Inc., a sustainable agricultural technology company developing novel biological crop pest protection products, announced today that it has raised $1.2 million in a seed financing round. The funding by Ospraie Ag Science (OAS), the venture arm of New York

CAMBRIDGE, Mass., March 2, 2020 /PRNewswire/ -- Boston Biomedical, Inc. announced today that its parent company, Sumitomo Dainippon Pharma Co., Ltd. (Osaka, Japan) has invested in the MPM Oncology Innovations Fund (hereinafter, "INV"), and made a donation to the Dana-Farber Innovations Research Fund (hereinafter, "IRF"). Th